Media

Nordic Nanovector ASA – Share capital increase registered

Vicore Pharma to host Key Opinion Leader webinar on C21 for the treatment of COVID-19

Oncopeptides submits application for conditional marketing authorization of melflufen in the EU

Vicore Pharma publishes the Annual Report for 2020

BONESUPPORT Holding AB publishes Annual Report 2020

Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivet’s Gene Therapy Programs Targeting Progressive Familial Intrahepatic Cholestasis

Nordic Nanovector ASA – Final results of the repair offering

Fusion Pharmaceuticals Announces Preclinical Combination Data Demonstrating Enhanced Efficacy In Multiple Preclinical Tumor Models

Nordic Nanovector ASA – Preliminary results of the repair offering

CARISMA Therapeutics to Present Data at The American Association for Cancer Research Annual Meeting